In the environment exactly where wellbeing and affordability collide, It really is striking how Novo Nordisk's copyright happens to be a lifeline For several. While the production expenditures appear affordable, the retail rates frequently depart you questioning the fairness of entry.California biotech behemoth Amgen ditched plans for an experiment